ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

NIH Will Target Genomics, Translational Research, And Training, Collins Tells Congress

April 30, 2010

Postdoc Fabricated Results In Published Study, ORI Says.

October 27, 2000

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975